Penta Labs is a dynamic generic pharmaceutical company with presence in South Asia and South East Asia (ASEAN countries), expanding to Africa (with products under registration in various countries).
We manufacture, market and export finished pharmaceutical dosage forms and Nutraceuticals. We have our own manufacturing facilities and also do toll manufacture of some of our products / brands of certain category of products which require separate facility. Our manufacturing facilities are approved by the leading international regulatory agencies.
On the back of strong year on year results since inception and powered by the best of managerial talent, we are now embarking on the next stage of our growth journey with the manufacture of certain specialities and expansion to new markets.
- 2003: Started toll manufacturing, registering own products/brands.
- 2006: Penta Labs was established as a separate company with the idea of manufacturing at own facility.
- 2007: Penta group acquired a strategic stake in a antibiotics manufacturer in South India
- 2011: Penta group acquires full stakes in a pharmaceutical unit in South India producing Oral Forms of genral category products.
To deliver quality products, information and resources to our customers, empowering them to achieve optimal growth in healthcare business and build mutually beneficial partnerships